Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Grynberg

Showing results (21-30 of 85) with videos related to

Pageof 9
Sort By:
Fertility and Sterility|June 5, 2012
Ovarian tissue and follicle transplantation as an option for fertility preservationMichael Grynberg, Marine Poulain, Sarah Sebag-Peyrelevade, et al.
Future Oncology (London, England)|September 12, 2015
The past, present and future of fertility preservation in cancer patientsCharlotte Sonigo, Nathalie Sermondade, Julie Benard, et al.
Plos One|September 24, 2020
Psychosocial and professional burden of Medically Assisted Reproduction (MAR): Results from a French surveyBlandine Courbiere, Arnaud Lacan, Michael Grynberg, et al.
Reproductive Biomedicine Online|April 27, 2020
Does the prognosis after PGT for structural rearrangement differ between female and male translocation carriers?Anne Mayeur, Naouel Ahdad, Laetitia Hesters, et al.
Plos One|December 7, 2018
Comparison of GnRH agonist and hCG for priming in vitro maturation cycles in cancer patients undergoing urgent fertility preservationHady El Hachem, Charlotte Sonigo, Julie Benard, et al.
Reproductive Biomedicine Online|March 4, 2014
Is it acceptable to destroy or include human embryos before day 5 in research programmes?Marine Poulain, Laetitia Hesters, Thibaut Sanglier, et al.
Future Oncology (London, England)|December 13, 2012
New trends in female fertility preservation: in vitro maturation of oocytesAna Luiza Berwanger, Astrid Finet, Hady El Hachem, et al.
Frontiers in Endocrinology|March 17, 2018
A Proof-of-Concept Clinical Trial of A Single Luteal Use of Long-Acting Gonadotropin-Releasing Hormone Antagonist Degarelix in Controlled Ovarian Stimulation for <i>In Vitro</i> Fertilization: Long Antagonist ProtocolEvangelos G Papanikolaou, Hakan Yarali, Evi Timotheou, et al.
BMC Medical Genetics|April 28, 2017
First mutation in the FSHR cytoplasmic tail identified in a non-pregnant woman with spontaneous ovarian hyperstimulation syndromeJustine Hugon-Rodin, Charlotte Sonigo, Anne Gompel, et al.
JBRA Assisted Reproduction|June 28, 2018
Are age and anti-Müllerian hormone good predictors of ovarian reserve and response in women undergoing IVF?Juliano Augusto Brum Scheffer, Bruno Scheffer, Rafaela Scheffer, et al.
Pageof 9

Showing results (21-30 of 85) with videos related to

Sort By:
Pageof 9
Fertility and Sterility|June 5, 2012
Ovarian tissue and follicle transplantation as an option for fertility preservationMichael Grynberg, Marine Poulain, Sarah Sebag-Peyrelevade, et al.
Future Oncology (London, England)|September 12, 2015
The past, present and future of fertility preservation in cancer patientsCharlotte Sonigo, Nathalie Sermondade, Julie Benard, et al.
Plos One|September 24, 2020
Psychosocial and professional burden of Medically Assisted Reproduction (MAR): Results from a French surveyBlandine Courbiere, Arnaud Lacan, Michael Grynberg, et al.
Reproductive Biomedicine Online|April 27, 2020
Does the prognosis after PGT for structural rearrangement differ between female and male translocation carriers?Anne Mayeur, Naouel Ahdad, Laetitia Hesters, et al.
Plos One|December 7, 2018
Comparison of GnRH agonist and hCG for priming in vitro maturation cycles in cancer patients undergoing urgent fertility preservationHady El Hachem, Charlotte Sonigo, Julie Benard, et al.
Reproductive Biomedicine Online|March 4, 2014
Is it acceptable to destroy or include human embryos before day 5 in research programmes?Marine Poulain, Laetitia Hesters, Thibaut Sanglier, et al.
Future Oncology (London, England)|December 13, 2012
New trends in female fertility preservation: in vitro maturation of oocytesAna Luiza Berwanger, Astrid Finet, Hady El Hachem, et al.
Frontiers in Endocrinology|March 17, 2018
A Proof-of-Concept Clinical Trial of A Single Luteal Use of Long-Acting Gonadotropin-Releasing Hormone Antagonist Degarelix in Controlled Ovarian Stimulation for <i>In Vitro</i> Fertilization: Long Antagonist ProtocolEvangelos G Papanikolaou, Hakan Yarali, Evi Timotheou, et al.
BMC Medical Genetics|April 28, 2017
First mutation in the FSHR cytoplasmic tail identified in a non-pregnant woman with spontaneous ovarian hyperstimulation syndromeJustine Hugon-Rodin, Charlotte Sonigo, Anne Gompel, et al.
JBRA Assisted Reproduction|June 28, 2018
Are age and anti-Müllerian hormone good predictors of ovarian reserve and response in women undergoing IVF?Juliano Augusto Brum Scheffer, Bruno Scheffer, Rafaela Scheffer, et al.
Pageof 9